Research ArticleArticle
Evaluation of NT-proBNP and High Sensitivity C-Reactive Protein for Predicting Cardiovascular Risk in Patients with Arthritis Taking Longterm Nonsteroidal Antiinflammatory Drugs
Christian T. Ruff, David A. Morrow, Peter Jarolim, Fang Ren, Charles F. Contant, Amarjot Kaur, Sean P. Curtis, Loren Laine, Christopher P. Cannon and Kay Brune
The Journal of Rheumatology April 2011, jrheum.100880; DOI: https://doi.org/10.3899/jrheum.100880
Christian T. Ruff
David A. Morrow
Peter Jarolim
Fang Ren
Charles F. Contant
Amarjot Kaur
Sean P. Curtis
Loren Laine
Christopher P. Cannon
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Evaluation of NT-proBNP and High Sensitivity C-Reactive Protein for Predicting Cardiovascular Risk in Patients with Arthritis Taking Longterm Nonsteroidal Antiinflammatory Drugs
Christian T. Ruff, David A. Morrow, Peter Jarolim, Fang Ren, Charles F. Contant, Amarjot Kaur, Sean P. Curtis, Loren Laine, Christopher P. Cannon, Kay Brune
The Journal of Rheumatology Apr 2011, jrheum.100880; DOI: 10.3899/jrheum.100880
Evaluation of NT-proBNP and High Sensitivity C-Reactive Protein for Predicting Cardiovascular Risk in Patients with Arthritis Taking Longterm Nonsteroidal Antiinflammatory Drugs
Christian T. Ruff, David A. Morrow, Peter Jarolim, Fang Ren, Charles F. Contant, Amarjot Kaur, Sean P. Curtis, Loren Laine, Christopher P. Cannon, Kay Brune
The Journal of Rheumatology Apr 2011, jrheum.100880; DOI: 10.3899/jrheum.100880